K-679, Novel

K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate with Ultra-High Drug Loading Capacity Demonstrates Superior Efficacy in EGFR-Expressing Solid Tumors

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Kowa Company Ltd. Japan Illinois

View original content:https://www.prnewswire.co.uk/news-releases/k-679-a-novel-antibody-drug-loaded-unimicelle-conjugate-with-ultra-high-drug-loading-capacity-demonstrates-superior-efficacy-in-egfr-expressing-solid-tumors-302430671.html

en | boerse | 67929504 |